Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K061190
    Date Cleared
    2006-09-15

    (140 days)

    Product Code
    Regulation Number
    862.1545
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    ACCESS INTACT PTH AND CALIBRATORS, MODELS A 16972 AND A 16953

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Access Intact PTH assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of intact parathyroid hormone (parathyrin, PTH) levels in human serum and plasma using the Access Immunoassay Systems. It is indicated to aid in the differential diagnosis of hyperparathyroidism, hypoparathyroidism, or hypercalcemia of malignancy and can be used intraoperatively. Assay results should be used in conjunction with other clinical data to assist the clinician in making individual patient management decisions.

    The Access Intact PTH Calibrators are intended to calibrate the Access Intact PTH assay for the quantitative determination of intact parathyroid hormone (parathyrin, PTH) levels in human serum and plasma using the Access Immunoassay Systems.

    Device Description

    The Access Intact PTH reagents, calibrators, and the Access Immunoassay Analyzers (Access, Access 2, Synchron LXi 725, UniCel DxC600i, and UniCel Dxl 800) comprise the Access Immunoassay Systems for the determination of intact parathyroid hormone (PTH) levels in human serum and plasma.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study information for the Access Intact PTH and Intact PTH Calibrators on the Access® Immunoassay Systems, based on the provided 510(k) summary:

    1. Table of Acceptance Criteria and Reported Device Performance

    Study TypeAcceptance Criteria (Implied)Reported Device Performance
    Imprecision (CV%)Not explicitly statedRoutine Mode: 2.8% to 6.4% CV (for 12-1400 pg/mL)
    Intraoperative Mode: 3.1% to 10.6% CV (for 12-1400 pg/mL)
    Dilution Recovery (Linearity)Not explicitly statedRoutine Mode: Mean % recovery 91% to 103%
    Intraoperative Mode: Mean % recovery 85% to 98%
    Methods Comparison (Routine vs. Predicate)Not explicitly statedRange: 16-2627 pg/mL
    Intercept: -11.5 pg/mL
    Slope: 1.09
    Correlation Coefficient (r): 0.99
    Methods Comparison (Routine vs. Intraoperative)Not explicitly statedRange: 13-2848 pg/mL
    Intercept: 9.69 pg/mL
    Slope: 0.94
    Correlation Coefficient (r): 1.00
    Methods Comparison (Intraoperative vs. Predicate)Not explicitly statedRange: 8-2453 pg/mL
    Intercept: 0.13 pg/mL
    Slope: 0.87
    Correlation Coefficient (r): 1.00
    Analytical SpecificityNo significant interferenceNo significant interference from bilirubin, hemoglobin, human serum albumin, and triglycerides.
    Stability (Reagents)Not explicitly stated28 days after opening
    Stability (Calibrators)Not explicitly statedSingle use only, calibration stable for 28 days
    Clinical Reference RangeNot explicitly stated12-88 pg/mL (95% non-parametric reference interval)

    *Note: The acceptance criteria are "implied" as specific thresholds were not explicitly stated in the 510(k) summary (e.g., "CV must be

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1